Cargando…
Potential biomarker of brain response to opioid antagonism in adolescents with eating disorders: a pilot study
BACKGROUND: Eating Disorders (ED) affect up to 5% of youth and are associated with reward system alterations and compulsive behaviors. Naltrexone, an opioid antagonist, is used to treat ED behaviors such as binge eating and/or purging. The presumed mechanism of action is blockade of reward activatio...
Autores principales: | Stancil, Stephani L., Yeh, Hung-Wen, Brucks, Morgan G., Bruce, Amanda S., Voss, Michaela, Abdel-Rahman, Susan, Brooks, William M., Martin, Laura E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363723/ https://www.ncbi.nlm.nih.gov/pubmed/37492067 http://dx.doi.org/10.3389/fpsyt.2023.1161032 |
Ejemplares similares
-
Effects of genotype and food on naltrexone exposure in adolescents
por: Stancil, Stephani L., et al.
Publicado: (2022) -
Long-Term NMDAR Antagonism Correlates Weight Loss With Less Eating
por: Deng, Shi-Ning, et al.
Publicado: (2019) -
Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date
por: Stancil, Stephani L, et al.
Publicado: (2021) -
A Systematic Review of Opioid Use Disorder and Related Biomarkers
por: Bryant, Bianca M., et al.
Publicado: (2021) -
Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
por: Segura-Garcia, Cristina, et al.
Publicado: (2021)